Vringo (VRNG) Launches New Version of Facetones Customized for Latest Nokia Mobile Devices
Vringo (VRNG) Launches New Version of Facetones Customized for Latest Nokia Mobile Devices
Amorcyte, a NeoStem (NBS) Company, Enrolls First Patient in Phase 2 Trial for AMR-001
Corporate Profile interviews Butch Flatt, CEO of ARCIS (ARCS)
Oramed Pharmaceuticals (ORMP) Granted Australian Patent
Vringo (VRNG) Announces New Version of Facetones App That Includes Enhanced Text Messaging
Medgenics (MDGN) Receives Allowance for Key European Patent
Pluristem (PSTI) Awarded a $2.4 Million Grant From Israeli Government
Rexahn (RNN) Secures Approval to Conduct a First-in-Human Trial of RX-3117
Vringo (VRNG) Launches Facetones™ App on the iPhone®
Implant Sciences’ (IMSC) Quantum Sniffer QS-H150 Deployed at Major International Bank in Middle East